In addition, serpin E1, leptin, c-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-alpha) were significantly decreased in T2DM patients using beinaglutide, demonstrating that beinaglutide also has an anti-inflammatory effect in T2DM patients [84]. This evidence concerns the gene CRP and type 2 diabetes mellitus.